Article
Next-Generation Sequencing of Lung Cancers: Lessons Learned and Future Directions.
Hematology/oncology clinics of North America - 1 Feb 2017
Devarakonda Siddhartha, Masood Ashiq, Govindan Ramaswamy
Abstract excerpt
Targeted therapies and immune checkpoint inhibitors have significantly improved outcomes in a sizable fraction of patients with metastatic non-small cell lung cancer. Nevertheless, a majority of patients with lung cancer continue to have poor outcomes. The ability to comprehensively characterize the genomic alterations in various subtypes of lung cancer has the potential to transform cancer care by facilitating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
